By Josh Beckerman
General Mills Inc. said it plans to eliminate another 500 jobs with the closures of two Pillsbury dough factories, adding to the roughly 1,400 job cuts it announced last year as it tries to improve profitability amid lackluster industry sales.
The head of national sales for Groupon Inc. (GRPN) has stepped down from his day-to-day role at the company to pursue an entrepreneurial venture, Re/code reported, citing a source familiar with the matter.
Recruitment completed rapidly into Part A of Phase 2/3 trial in Dravet syndrome
Part B of Phase 2/3 trial and second Phase 3 trial in Dravet syndrome to start Q1 2015
Top line Phase 3 data expected by the end of 2015
Two Phase 3 trials in Lennox-Gastaut syndrome to start Q1 2015
220 children currently on treatment in U.S. expanded access program, additional data expected during H1 2015
Phase 2 CBDV epilepsy trial due to commence Q1 2015
U.S. Notice of Allowance received for patent covering use of CBD in treatment of partial seizures -Conference call and webcast at 8:00 a.m. EST, 1:00 p.m. GMT to discuss this and other press release issued today-
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of DaVita HealthCare Partners Inc., JPS Industries, Inc., Meadowbrook Insurance Group, Inc., Medbox, Inc., State Investors Bancorp, Inc. and Uranerz Energy Corporation investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced
today that its partner Melinta Therapeutics reported positive top-line
results from the first of two Phase 3 PROCEED studies (study
RX-3341-302, NCT01811732) to evaluate delafloxacin, an investigational
fluoroquinolone, compared with vancomycin + aztreonam for the treatment
of patients with acute bacterial skin and skin structure infections
(ABSSSI). Delafloxacin met the study’s primary objective endpoint of a
reduction in the measurement of lesion erythema at the primary infection
site at 48- to- 72 hours, the endpoint required by the U.S. Food and
Drug Administration (FDA). Delafloxacin also was comparable to
vancomycin in the study’s secondary endpoints, including investigator
assessment of signs and symptoms of infection at the follow-up visit, a
metric required by the European Medicines Agency (EMA).
Marsh & McLennan Agency LLC (MMA), a subsidiary of Marsh, a global
leader in insurance broking and risk management, today announced that it
has acquired The
Benefit Planning Group, Inc. , a Durham, North Carolina-based
employee benefit consulting firm.
Morgan Stanley today announced that Morgan Stanley Credit Partners,
which is part of the Firm’s Merchant Banking & Real Estate Investing
business, has raised aggregate commitments of approximately $1 billion
for Morgan Stanley Credit Partners II, L.P., the Firm’s second
investment vehicle targeting corporate mezzanine debt and related
instruments issued by middle market companies in North America and
Myers Industries, Inc. (NYSE:MYE), an international manufacturer of
polymer products and wholesale distributor servicing the under vehicle
service industry in the U.S., announced today that it has entered into a
definitive agreement to sell its Lawn & Garden business for $115 million
to an entity controlled by Wingate Partners V, L.P., a Dallas, TX based
private equity firm.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.